Morning Trend | Tonix Pharmaceuticals Holding experiences significant intraday volatility, is a rebound trend about to start?
Tonix Pharmaceuticals Holdings (TNXP.US) showed a significant surge in trading volume yesterday, with the previously stagnant small-cap pharmaceutical stocks experiencing a return of institutional investors, and community FOMO sentiment gradually rising. The stock price broke through short-term moving average resistance, igniting trading enthusiasm in the morning session, as bulls attempted to dominate the market. Although there are currently no major favorable policies in the pharmaceutical industry, speculation surrounding vaccine development and industry policy adjustments has resurfaced, transmitting to the small-cap biotech sector, where capital competition is rapidly heating up. Institutions quickly built positions and lifted prices in the low volatility zone, raising short-term attention. Technically, the daily K-line formed a large bullish candle, breaking through the upper band of the moving average system, with the MACD indicator also turning upward. The main funds made three upward pushes in intraday trading, with sufficient follow-up capital, indicating strong momentum. Today, attention should be paid to whether the gentle increase in volume can be sustained. If the short-term enthusiasm for chasing prices continues, it may ignite a rally in small-cap pharmaceutical stocks. Caution is needed against potential follow-up buying failing to sustain, which could lead to a quick cooling of the market as institutions take profits. For right-side traders, Tonix's intraday volatility today is an important signal for the initiation of a rebound trend
Tonix Pharmaceuticals Holdings (TNXP.US) showed a significant surge in trading volume during yesterday's session, with the previously stagnant small-cap pharmaceutical stocks experiencing a return of institutional investors, and community FOMO sentiment gradually rising. The stock price broke through short-term moving average resistance, igniting trading enthusiasm in the morning, as bulls attempted to dominate the market.
The pharmaceutical industry currently lacks major favorable policies, but speculation around vaccine development and industry policy adjustments has resurfaced, transmitting to the small-cap biotech sector, where capital competition is rapidly heating up. Institutions quickly built positions and lifted prices in a low volatility zone, raising short-term attention.
From a technical perspective, the daily K-line formed a large bullish candle, breaking through the upper band of the moving average system, with the MACD indicator also turning upward. The main funds made three upward pushes in intraday trading, with sufficient follow-up capital, indicating strong momentum.
Today, attention should be paid to whether the gentle increase in volume can be sustained. If the short-term enthusiasm for chasing prices continues, it may ignite a rally in small-cap pharmaceutical stocks. Caution is needed against potential follow-up buying failing to sustain momentum, which could lead to a quick cooling of the market as institutions take profits. For right-side traders, Tonix's intraday volatility today is an important signal for the initiation of a rebound trend
